PAPER Conejero-Goldberg C, Davies P, Ulloa L

Alpha7 nicotinic acetylcholine receptor: a link between inflammation and neurodegeneration.

Neurosci Biobehav Rev. 2008;32(4):693-706. PubMed: 18180036

PAPER Chen Y, Dyakin VV, Branch CA, Ardekani B, Yang D, Guilfoyle DN, Peterson J, Peterhoff C, Ginsberg SD, Cataldo AM, Nixon RA

In vivo MRI identifies cholinergic circuitry deficits in a Down syndrome model.

Neurobiol Aging. 2009 Sep;30(9):1453-65. PubMed: 18180075

PAPER Keating DJ, Dubach D, Zanin MP, Yu Y, Martin K, Zhao YF, Chen C, Porta S, Arbonés ML, Mittaz L, Pritchard MA

DSCR1/RCAN1 regulates vesicle exocytosis and fusion pore kinetics: implications for Down syndrome and Alzheimer's disease.

Hum Mol Genet. 2008 Apr 1;17(7):1020-30. PubMed: 18180251

PAPER MacKenzie SM, Dewar D, Stewart W, Fraser R, Connell JM, Davies E

The transcription of steroidogenic genes in the human cerebellum and hippocampus: a comparative survey of normal and Alzheimer's tissue.

J Endocrinol. 2008 Jan;196(1):123-30. PubMed: 18180323

PAPER Chua TC, Wen W, Slavin MJ, Sachdev PS

Diffusion tensor imaging in mild cognitive impairment and Alzheimer's disease: a review.

Curr Opin Neurol. 2008 Feb;21(1):83-92. PubMed: 18180656

PAPER Zheng F, Adelsberger H, Müller MR, Fritschy JM, Werner S, Alzheimer C

Activin tunes GABAergic neurotransmission and modulates anxiety-like behavior.

Mol Psychiatry. 2009 Mar;14(3):332-46. PubMed: 18180762

PAPER Wuertzer CA, Sullivan MA, Qiu X, Federoff HJ

CNS delivery of vectored prion-specific single-chain antibodies delays disease onset.

Mol Ther. 2008 Mar;16(3):481-6. PubMed: 18180775

PAPER Macdonald A, Briggs K, Poppe M, Higgins A, Velayudhan L, Lovestone S

A feasibility and tolerability study of lithium in Alzheimer's disease.

Int J Geriatr Psychiatry. 2008 Jul;23(7):704-11. PubMed: 18181229

PAPER Borroni B, Archetti S, Costanzi C, Grassi M, Ferrari M, Radeghieri A, Caimi L, Caltagirone C, Di Luca M, Padovani A,

Role of BDNF Val66Met functional polymorphism in Alzheimer's disease-related depression.

Neurobiol Aging. 2009 Sep;30(9):1406-12. PubMed: 18179845

PAPER McKeith I

Dementia with Lewy bodies and Parkinson's disease with dementia: where two worlds collide.

Pract Neurol. 2007 Nov;7(6):374-82. PubMed: 18024777

PAPER Noy D, Solomonov I, Sinkevich O, Arad T, Kjaer K, Sagi I

Zinc-amyloid beta interactions on a millisecond time-scale stabilize non-fibrillar Alzheimer-related species.

J Am Chem Soc. 2008 Jan 30;130(4):1376-83. PubMed: 18179213

PAPER Yang X, Yang Y, Li G, Wang J, Yang ES

Coenzyme Q10 attenuates beta-amyloid pathology in the aged transgenic mice with Alzheimer presenilin 1 mutation.

J Mol Neurosci. 2008 Feb;34(2):165-71. PubMed: 18181031

α-Synuclein

ANTIBODY polyclonal manufacturer Cat# 18-272-196446 immunogen = synthetic peptide near the C-terminus of human α-synuclein liquid, PBS, BSA, azide, affinity purified α-synuclein; does not react with β-synuclein Synucleins GenWay Biotech Rabbit α-Synuclein

α-Synuclein

ANTIBODY polyclonal manufacturer Cat# 18-272-196445 immunogen = synthetic peptide corresp. to aa 111-131 near the C-terminus of human α-synuclein liquid, PBS, BSA, azide, affinity purified α-synuclein; does not react with β-synuclein Synucleins GenWay Biotech Rabb

α-Synuclein (4D6)

ANTIBODY monoclonal 4D6 manufacturer Cat# 20-272-192256 immunogen = recomb. human alpha-synuclein produced in E. coli. liquid, supernatant, purified, PBS, no preservative α-synuclein IgG₁ Synucleins GenWay Biotech Mouse α-Synuclein